We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Commercial Kit Enables Rapid Assessment of Chromatin Structure

By LabMedica International staff writers
Posted on 13 Feb 2011
A commercial kit is now available that enables the rapid quantitative assessment of chromatin structure by quantitatively differentiating expressed (accessible) and silent (inaccessible) regions of the genome.

The Bio-Rad Laboratories (Hercules, CA, USA) EpiQ chromatin analysis kit was designed to complement existing epigenetic assays such as DNA methylation and chromatin immunoprecipitation. More...
These measurements detect whether epigenetic processes such as DNA methylation or histone modification have caused changes in gene expression.

The EpiQ chromatin analysis kit was designed to differentiate between genes that are being actively transcribed (euchromatin) and silent genes (heterochromatin). The selective nuclease provided in the kit can only act on euchromatin. The difference in the amount of DNA detected by the kit's PCR reagents before and after nuclease digestion reveals the extent to which the target gene is expressed.

The EpiQ kit includes buffers for cell permeabilization and in situ chromatin digestion, optimized nuclease, materials for genomic DNA purification, control assays (qPCR primers) for chromatin assessment of a reference (epigenetically silenced) and control (constitutively expressed) gene, and EpiQ Chromatin SYBR Green Supermix, a real-time PCR reagent designed to amplify genomic DNA.

The EpiQ kit permits assessment of chromatin structure in as few as 50,000 cultured cells within six hours, and it can generate quantitative chromatin structure information for multiple genomic elements.

"The EpiQ chromatin analysis kit provides researchers with an easy and fast way to quantify a gene's chromatin state,” said Viresh Patel, marketing manager for PCR reagents at Bio-Rad. "Using the kit, cancer, developmental, and stem cell biology researchers are able to glean direct information regarding the chromatin state that is associated with epigenetic marks such as DNA methylation and histone modifications for the first time."

Related Links:
Bio-Rad Laboratories



New
Gold Member
Immunochromatographic Assay
CRYPTO Cassette
POC Helicobacter Pylori Test Kit
Hepy Urease Test
New
Gold Member
Hematology Analyzer
Medonic M32B
New
Gram-Negative Blood Culture Assay
LIAISON PLEX Gram-Negative Blood Culture Assay
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Hematology

view channel
Image: Platelets sequester cfDNA during circulation (Murphy L. et al., Science, 2025; DOI: 10.1126/science.adp3971)

Platelets Could Improve Early and Minimally Invasive Detection of Cancer

Platelets are widely recognized for their role in blood clotting and scab formation, but they also play a crucial role in immune defense by detecting pathogens and recruiting immune cells.... Read more

Immunology

view channel
Image: The test could streamline clinical decision-making by identifying ideal candidates for immunotherapy upfront (Xiao, Y. et al. Cancer Biology & Medicine July 2025, 20250038)

Blood Test Predicts Immunotherapy Efficacy in Triple-Negative Breast Cancer

Triple-negative breast cancer (TNBC) is an aggressive subtype lacking targeted therapies, making immunotherapy a promising yet unpredictable option. Current biomarkers such as PD-L1 expression or tumor... Read more

Microbiology

view channel
Image: New diagnostics could predict a woman’s risk of a common sexually transmitted infection (Photo courtesy of 123RF)

New Markers Could Predict Risk of Severe Chlamydia Infection

Chlamydia trachomatis is a common sexually transmitted infection that can cause pelvic inflammatory disease, infertility, and other reproductive complications when it spreads to the upper genital tract.... Read more

Pathology

view channel
image: Researchers Marco Gustav (right) and MD Nic G. Reitsam (left) discuss the study data (Photo courtesy of Anja Stübner/EKFZ)

AI Model Simultaneously Detects Multiple Genetic Colorectal Cancer Markers in Tissue Samples

Colorectal cancer is a complex disease influenced by multiple genetic alterations. Traditionally, studies and diagnostic tools have focused on predicting only one mutation at a time, overlooking the interplay... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.